Skip to main content
    E

    Enveric Biosciences Inc (ENVB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.41
    -0.03 (-2.08%)

    Market Cap: $6.45M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Enveric Biosciences Inc (ENVB) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Enveric Biosciences (ENVB) has a market cap of $6.45M and an enterprise value of $832.31K. It holds $5.61M more cash than debt, 87.09% of its market cap.

    Total Valuation

    Enterprise value is 87.09% below the market cap, as cash exceeds debt.

    Market Cap$6.45M
    Enterprise Value$832.31K
    Latest price (Nov 17, 2026)$1.41

    Key Dates

    The next earnings report is expected on Mar 25, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 25, 2027 (expected)
    Last Earnings DateNov 13, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 12.46% in the quarter ended Sep 30, 2026.

    Shares Outstanding4.48M
    Shares Change (QoQ)+12.46%

    Valuation Ratios

    Sales and book value multiples are 0.2x and 1.1x.

    P/S Ratio0.2x
    P/B Ratio1.1x

    Price Statistics

    The stock is down 73.30% over 52 weeks and trades 4.08% below its 50-day average.

    Beta (1Y)0.77
    52-Week Change-73.30%
    1-Month Change+1.44%
    3-Month Change+7.63%
    6-Month Change-33.18%
    5-Year Change-99.99%
    Total Return (1Y)-73.30%
    Total Return (3Y CAGR)-82.64%
    Total Return (5Y CAGR)-84.28%
    Return vs SPY (1Y)-86.69%
    Max Drawdown (1Y)-87.71%
    Max Drawdown (3Y)-99.58%
    Sharpe Ratio (1Y)-0.99
    Correlation with SPY (1Y)0.08
    50-Day Average$1.47
    200-Day Average$1.88
    52-Week Range$1.17 to $13.25
    RSI (14 Days)45.0
    Average Volume (20 Days)31.39K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 9.70x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio9.70x
    Quick Ratio9.70x
    Debt / Equity0.00x
    Interest Coverage-7800.00x

    Returns and Efficiency

    Return on Assets (ROA)-137.00%
    Receivables Turnover4720.68x

    Scores

    ENVB has an Altman Z-Score of -18.84, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score-18.84
    Altman Z ZoneDistress
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Balance Sheet

    Cash and Equivalents$5.61M
    Total Debt$0
    Net Cash$5.61M
    Net Cash Per Share$1.25

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Dividends and Yields

    ENVB does not pay a dividend. Its free cash flow yield is -144.53%.

    FCF Yield-144.53%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 1-for-12 reverse split on Oct 28, 2025.

    Last Split DateOct 28, 2025
    Split TypeReverse split
    Split Ratio1:12

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About ENVB

    What is ENVB's market cap?

    Enveric Biosciences has a market cap of $6.45M. Its enterprise value, which adds debt and subtracts cash, is $832.31K.

    How many shares of ENVB are outstanding?

    Enveric Biosciences has 4.48M shares outstanding.

    Does ENVB pay a dividend?

    No. Enveric Biosciences does not pay a dividend.

    How much debt does ENVB have?

    Enveric Biosciences has $0 of total debt and $5.61M of cash and equivalents, a net cash position of $5.61M.